News on Bone_Cancer from BioPortfolio.com http://www.BioPortfolio.com Consolidated Bone_Cancer news from BioPortfolio.com Wed, 10 Feb 2010 12:38:13 GMT en Amgen Tops Novartis at Reducing Fractures in Prostate Patientshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040747&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040747&THISHREF=http://c.moreover.com/click/here.pl%3fz2538857698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040747&HITNO=0&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040747&THISHREF=http://c.moreover.com/click/here.pl%3fz2538857698%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCafepharma: Treatment Of Rare Type Of Bone Tumour: Promising Results With Denosumabhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040377&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040377&THISHREF=http://c.moreover.com/click/here.pl%3fz2538713134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040377&HITNO=1&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040377&THISHREF=http://c.moreover.com/click/here.pl%3fz2538713134%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Denosumab Demonstrated Superiority Over Zometa in Pivotal Phase 3 Head-to-Head Trial in Prostate Cancer Patienhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038826&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038826&THISHREF=http://c.moreover.com/click/here.pl%3fz2537788458%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038826&HITNO=2&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038826&THISHREF=http://c.moreover.com/click/here.pl%3fz2537788458%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Cancer Bats Preview New Album With Online Song Postinghttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039629&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039629&THISHREF=http://c.moreover.com/click/here.pl%3fz2538268939%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039629&HITNO=3&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039629&THISHREF=http://c.moreover.com/click/here.pl%3fz2538268939%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAntiMusic: Woman who faked cancer won't contest fraud, forgery chargeshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041130&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041130&THISHREF=http://c.moreover.com/click/here.pl%3fz2539006884%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041130&HITNO=4&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041130&THISHREF=http://c.moreover.com/click/here.pl%3fz2539006884%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDenver Post: Amgen's denosumab offers hope in rare bone tumourshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039542&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039542&THISHREF=http://c.moreover.com/click/here.pl%3fz2538200499%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039542&HITNO=5&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039542&THISHREF=http://c.moreover.com/click/here.pl%3fz2538200499%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Malaysia: Amgen's denosumab offers hope in rare bone tumourshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039012&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039012&THISHREF=http://c.moreover.com/click/here.pl%3fz2537870050%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039012&HITNO=6&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039012&THISHREF=http://c.moreover.com/click/here.pl%3fz2537870050%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comInteractive Investor: Amgen's denosumab offers hope in rare bone tumourshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038995&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038995&THISHREF=http://c.moreover.com/click/here.pl%3fz2537865695%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038995&HITNO=7&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038995&THISHREF=http://c.moreover.com/click/here.pl%3fz2537865695%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters: Amgen's denosumab offers hope in rare bone tumourshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038880&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038880&THISHREF=http://c.moreover.com/click/here.pl%3fz2537820441%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038880&HITNO=8&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038880&THISHREF=http://c.moreover.com/click/here.pl%3fz2537820441%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSharenet: Amgen's denosumab offers hope in rare bone tumourshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038837&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038837&THISHREF=http://c.moreover.com/click/here.pl%3fz2537795364%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038837&HITNO=9&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038837&THISHREF=http://c.moreover.com/click/here.pl%3fz2537795364%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: Denosumab Trial met Primary and all Secondary Endpointshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040254&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040254&THISHREF=http://c.moreover.com/click/here.pl%3fz2538675776%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040254&HITNO=10&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040254&THISHREF=http://c.moreover.com/click/here.pl%3fz2538675776%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comWorld Pharma News: D-Mab Ascending Bone Throne: Phase III Strong in Prostate, toohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039485&HITNO=11&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039485&THISHREF=http://c.moreover.com/click/here.pl%3fz2538147883%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: Skin cancerhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040690&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040690&THISHREF=http://c.moreover.com/click/here.pl%3fz2538839953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040690&HITNO=12&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040690&THISHREF=http://c.moreover.com/click/here.pl%3fz2538839953%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comKIMT.COM: Amgen Sees Positive Data in Bone Drug Studyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039885&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039885&THISHREF=http://c.moreover.com/click/here.pl%3fz2538447805%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039885&HITNO=13&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039885&THISHREF=http://c.moreover.com/click/here.pl%3fz2538447805%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceuticalProcessing: Amgen's denosumab offers hope in rare bone tumourshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038867&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038867&THISHREF=http://c.moreover.com/click/here.pl%3fz2537811058%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038867&HITNO=14&MSIZE=1000&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Bone_Cancer&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038867&THISHREF=http://c.moreover.com/click/here.pl%3fz2537811058%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comReuters UK: